| 2002 |
C. elegans ZYX-1 (zyxin orthologue) binds GLH germline RNA helicases, as demonstrated by yeast two-hybrid screening and independent GST pull-down assays. ZYX-1 is a LIM-domain protein most similar to vertebrate zyxin. |
Yeast two-hybrid screen; GST pull-down assay |
Developmental biology |
Medium |
12435362
|
| 2007 |
C. elegans ZYX-1 interacts with DYC-1 (a dystrophin-associated protein) at dense bodies in muscle. The interaction was mapped to a conserved 19-amino-acid sequence in DYC-1 that is sufficient for dense-body targeting, placing ZYX-1 at the C. elegans sarcomeric adhesion structure. |
Yeast two-hybrid assay; immunolocalization; domain-mapping experiments |
Molecular biology of the cell |
Medium |
18094057
|
| 2013 |
C. elegans ZYX-1 localizes to dense bodies/Z-discs and M-lines in striated body-wall muscle and shuttles into the nucleus, suggesting a signal-transduction role. ZYX-1 interacts with DEB-1/vinculin and ATN-1/α-actinin by yeast two-hybrid. Localization and dynamics at dense bodies depend on ATN-1. FRAP reveals high mobility of ZYX-1 at these structures, consistent with a peripheral, dynamic association. Two isoforms (ZYX-1a and ZYX-1b) play distinct roles in dystrophin-dependent muscle degeneration. |
Yeast two-hybrid; fluorescence microscopy; FRAP; isoform-specific analysis; C. elegans genetics |
Molecular biology of the cell |
High |
23427270
|
| 2014 |
C. elegans ZYX-1 maintains mechanosensory synapse integrity against locomotion-induced mechanical forces in vivo. The synapse-stabilizing activity is mediated by the C-terminal LIM domains alone; the N-terminal domain (which binds α-actinin and ENA-VASP) is dispensable for this function. |
C. elegans genetics (loss-of-function mutants); locomotion suppression epistasis; isoform rescue experiments |
Development (Cambridge, England) |
High |
25252943
|
| 2020 |
ZYX promotes invasion of human glioblastoma cells; ZYX loss reduces invasion. RNA-seq and mass spectrometry identified STMN1 as a downstream target whose mRNA and protein levels are positively regulated by ZYX. STMN1 rescues the invasion deficit caused by ZYX knockdown, placing ZYX upstream of STMN1 in a pro-invasive axis. |
ZYX knockdown/overexpression; RNA-seq; mass spectrometry; STMN1 rescue experiments; in vitro invasion assays; in vivo experiments |
Laboratory investigation |
Medium |
31949244
|
| 2020 |
A peptide fragment of ZYX (ZYX36-58) inhibits invasion and migration and promotes apoptosis of ovarian cancer cells. Mechanistically, ZYX36-58 binds and up-regulates the antiangiogenic/tumor-suppressive protein thrombospondin-1 (TSP1), as shown by peptide pull-down assay. |
Peptide pull-down assay; CCK8, transwell, wound-healing, and flow cytometry assays; RNA-seq |
Annals of translational medicine |
Medium |
32953725
|
| 2022 |
C. elegans ZYX-1/Zyxin is recruited to apical junctions in dorsal and ventral epidermal cells during embryonic elongation when junctions are under tension. Its LCR region is recruited to stress fiber strain sites in cultured vertebrate cells. Loss of ZYX-1 causes junctional F-actin defects and enhances morphogenetic defects in cadherin/catenin complex hypomorphs, establishing ZYX-1 as part of a tension-sensitive system that stabilizes junctional actin during morphogenesis. |
C. elegans genetics; fluorescence imaging; genetic epistasis with CCC hypomorphs; vertebrate cell culture SFSS recruitment assay |
Current biology : CB |
High |
36384139
|
| 2024 |
Endothelial zyxin acts as a mechanosensor under oscillatory shear stress (OSS) and promotes YAP nuclear translocation and endothelial inflammation. Mechanistically, zyxin interacts with 14-3-3β and inhibits 14-3-3β-facilitated phosphorylation of YAP at Serine 127, thereby reducing cytoplasmic retention of YAP and allowing nuclear YAP-driven inflammatory gene expression. EC-specific zyxin knockout in ApoE−/− mice reduces OSS-induced atherosclerosis. |
Endothelial cell-specific knockout mouse model (ZyxiniECKO ApoE−/−); disturbed-flow in vitro system; mechanistic co-immunoprecipitation/interaction studies with 14-3-3β and YAP; phosphorylation analysis |
bioRxiv (preprint)preprint |
Medium |
|
| 2024 |
ZYX acts downstream of ITGB1 in hepatocellular carcinoma cells. ITGB1 knockdown suppresses the FAK/AKT pathway; ZYX knockdown phenocopies this and also suppresses the FAK/AKT pathway. ZYX knockdown inhibits the growth-promoting effect of ITGB1 overexpression, while ZYX knockdown has no effect on ITGB1 expression, placing ZYX downstream of ITGB1 in the ITGB1/ZYX/FAK/AKT axis governing EMT and apoptosis. |
siRNA knockdown; overexpression rescue; in vivo xenograft model; Western blot for pathway components |
Cancer cell international |
Medium |
39143566
|
| 2025 |
Zyxin restricts viral envelope fusion and entry broadly across multiple virus families (HSV-1, PRV, paramyxovirus, rhabdovirus). Zyxin-KO cells show enhanced cell-cell fusion and larger viral plaques. Bulk RNA-seq of zyxin-KO cells identified altered expression of genes related to membrane potential, extracellular matrix organization, and MAPK cascade regulation, suggesting zyxin influences membrane properties relevant to viral fusion. |
CRISPR/Cas9 knockout; quantitative cell-cell fusion assay; plaque assay; bulk RNA-seq |
bioRxiv (preprint)preprint |
Medium |
|
| 2025 |
Zyxin and VASP cooperate to assemble dense, uniformly polar actin bundles at focal adhesions with barbed ends oriented toward the cell edge. CRISPR/Cas9 knockout of zyxin and/or VASP alters FA morphology and dynamics. Cryo-ET resolves the polarity of actin filaments at FAs; the tropomyosin-decorated dorsal actin layer is unaffected by zyxin/VASP loss, revealing layered FA architecture. |
CRISPR/Cas9 knockout; cryo-electron tomography; live-cell imaging of FA dynamics |
bioRxiv (preprint)preprint |
Medium |
|
| 2025 |
RAD51-AS1 lncRNA activates ZYX transcription via the HNRNPC/RARA axis in prostate cancer cells. RAD51-AS1 recruits HNRNPC to bind pre-RARA mRNA, positively modulating RARA expression; RARA in turn activates ZYX transcription. This pathway suppresses PCa cell migration and invasion, and rescue assays confirm RAD51-AS1 acts through ZYX. |
RT-qPCR; RIP/RNA binding assays; transcription reporter/ChIP-type analysis; knockdown/overexpression rescue assays; functional migration/invasion assays |
Discover oncology |
Medium |
41134509
|
| 2025 |
Coumestrol (CMS) binds ZYX directly (molecular docking supported by cell biology), down-regulates ZYX expression, and reduces TGF-β/SMAD pathway activity, thereby inhibiting ferroptosis in pancreatic acinar cells. ZYX overexpression counteracts the inhibitory effects of CMS on TGF-β/SMAD signaling and ferroptosis, placing ZYX upstream of TGF-β/SMAD in acinar cell ferroptosis. |
Molecular docking; WGCNA/network pharmacology; ZYX overexpression epistasis; in vivo caerulein-induced AP mouse model; ferroptosis assays |
International immunopharmacology |
Low |
40414075
|